Gabamide

Gabamide
Clinical data
Other names	GABAmide; GABAMIDE; GABA amide; 4-Aminobutanamide; 4-ABAD; 4-Aminobutyramide; gamma-Aminobutyramide; γ-Aminobutyramide; GABAD; gamma-Aminobutyric acid amide; γ-Aminobutyric acid amide
Drug class	GABA receptor agonist
ATC code	None;
Identifiers
	IUPAC name 4-aminobutanamide;
CAS Number	3251-08-9;
PubChem CID	18615;
ChemSpider	17581;
UNII	DQN3YXP96S;
ChEMBL	ChEMBL1199935;
CompTox Dashboard (EPA)	DTXSID80186235 ;
ECHA InfoCard	100.019.852
Chemical and physical data
Formula	C4H10N2O
Molar mass	102.137 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C(CC(=O)N)CN;
	InChI InChI=1S/C4H10N2O/c5-3-1-2-4(6)7/h1-3,5H2,(H2,6,7); Key:WCVPFJVXEXJFLB-UHFFFAOYSA-N;

Gabamide, or GABAmide, also known as γ-aminobutyramide (GABAD), is a GABA receptor agonist and GABA analogue, or more specifically the amide of the inhibitory neurotransmitter γ-aminobutyric acid (GABA).^[1]^[2] Along with GABA and progabide acid (SL-75.102), gabamide is an active metabolite of the anticonvulsant drug progabide (Gabrene; SL-76.002).^[1]^[2] Unlike progabide, but similarly to GABA, gabamide is unable to cross the blood–brain barrier and hence is peripherally selective.^[2] However, gabamide and GABA are formed in the brain from progabide following its entry into this part of the body.^[2]

References

^ ^a ^b Bartholini G (1981). "Present Knowledge of GABA Receptor Agonists". Medicinal Chemistry Advances. Elsevier. pp. 345–353. doi:10.1016/b978-0-08-025297-1.50032-5. ISBN 978-0-08-025297-1. Retrieved 6 October 2025.
^ ^a ^b ^c ^d Bergmann KJ (1985). "Progabide: a new GABA-mimetic agent in clinical use". Clinical Neuropharmacology. 8 (1): 13–26. doi:10.1097/00002826-198503000-00002. PMID 2983890. Progabide, a new synthetic compound defined as the Schiff base of gamma-aminobutyramide and a substituted benzophenone, has been developed. Well absorbed, and relatively free of toxicity, it is both a direct GABA receptor agonist as well as an exogenous source of GABA. [...]